8 studies found for:    AMR-001
Show Display Options
Rank Status Study
1 Active, not recruiting AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
Condition: ST Segment Elevation Myocardial Infarction
Interventions: Biological: AMR-001;   Other: placebo
2 Completed Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
Conditions: Myocardial Infarction;   Coronary Artery Disease
Intervention: Drug: Intra-coronary infusion
3 Completed AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
Condition: Small Cell Lung Cancer
Interventions: Drug: Amrubicin;   Drug: Topotecan
4 Active, not recruiting A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus
Condition: Chronic Hepatitis C
Interventions: Drug: TMC647055;   Drug: TMC435;   Drug: Ritonavir;   Drug: Ribavirin;   Drug: Pegylated interferon alpha-2a (PegIFN);   Drug: GSK2336805
5 Active, not recruiting Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
Condition: Antibody Mediated Rejection
Intervention: Drug: Eculizumab
6 Withdrawn Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: Amrubicin
7 Completed Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection
Condition: Kidney Transplantation
Intervention: Biological: C1 Esterase Inhibitor
8 Recruiting Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension
Conditions: Renal Artery Stenosis;   Hypertension, Renovascular
Intervention: Device: iCAST™ Rx Stent System

Indicates status has not been verified in more than two years